Dow Jones

38 886,17

0,20%

DAX

Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Correvio Pharma Corporation (CORV)
Correvio Pharma Corporation (CORV) Actualités

CORV

Correvio Pharma (CORV)

Correvio Pharma Corporation

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:CORV

1 2 3 4 5 6 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
09/06/2020	12h02	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(g) (15-12g)	NASDAQ:CORV	Correvio Pharma Corporation
28/05/2020	12h00	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	22h24	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	19h01	Edgar (US Regulatory)	Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	12h06	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement for Securities of Certain Canadian Issuers Under the Securities Act of 193...	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	12h03	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:CORV	Correvio Pharma Corporation
27/05/2020	12h02	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:CORV	Correvio Pharma Corporation
26/05/2020	23h30	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:CORV	Correvio Pharma Corporation
21/05/2020	22h01	PR Newswire (US)	Correvio Obtains Final Order for Plan of Arrangement	NASDAQ:CORV	Correvio Pharma Corporation
15/05/2020	23h55	PR Newswire (Canada)	Correvio Announces Results from Annual General and Special Meeting of Securityholders	NASDAQ:CORV	Correvio Pharma Corporation
06/05/2020	14h00	PR Newswire (US)	Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVAN...	NASDAQ:CORV	Correvio Pharma Corporation
04/05/2020	14h00	PR Newswire (US)	Correvio Announces Postponement of Its First Quarter 2020 Financial Results Due to Impacts From COVID-19	NASDAQ:CORV	Correvio Pharma Corporation
01/05/2020	14h00	PR Newswire (US)	Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA	NASDAQ:CORV	Correvio Pharma Corporation
30/04/2020	12h23	Edgar (US Regulatory)	Annual and Transition Report (foreign Private Issuer) (20-f)	NASDAQ:CORV	Correvio Pharma Corporation
21/04/2020	03h56	PR Newswire (US)	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers; Are Shareholders Getting a Fair Deal?	NASDAQ:CORV	Correvio Pharma Corporation
16/04/2020	23h30	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:CORV	Correvio Pharma Corporation
08/04/2020	22h05	PR Newswire (Canada)	Correvio Obtains Interim Order For Plan Of Arrangement	NASDAQ:CORV	Correvio Pharma Corporation
30/03/2020	13h00	PR Newswire (Canada)	Correvio Reports Full Year 2019 Financial Results	NASDAQ:CORV	Correvio Pharma Corporation
16/03/2020	12h00	PR Newswire (Canada)	ADVANZ PHARMA to Acquire Correvio	NASDAQ:CORV	Correvio Pharma Corporation
10/03/2020	12h30	PR Newswire (US)	Correvio Partners with Hong Kong Teson Pharma Limited for the Commercialization of Aggrastat® in China	NASDAQ:CORV	Correvio Pharma Corporation
02/03/2020	14h30	PR Newswire (US)	Correvio Responds to Market Activity	NASDAQ:CORV	Correvio Pharma Corporation
28/01/2020	14h00	PR Newswire (US)	Correvio Receives NASDAQ Notification Regarding Deficiencies In Minimum Bid Price And Market Value Of Listed Securities	NASDAQ:CORV	Correvio Pharma Corporation
09/01/2020	07h05	PR Newswire (US)	LEAD PLAINTIFF DEADLINE: Johnson Fistel, LLP Encourages Investors to Contact the Firm	NASDAQ:CORV	Correvio Pharma Corporation
24/12/2019	14h00	PR Newswire (Canada)	Correvio Receives Complete Response Letter From U.S. FDA for Brinavess and Provides Update on Recent Events	NASDAQ:CORV	Correvio Pharma Corporation
16/12/2019	23h36	Business Wire	Shareholder Alert: Robbins LLP Announces Correvio Pharma Corp. (CORV) Sued for Misleading Shareholders	NASDAQ:CORV	Correvio Pharma Corporation
11/12/2019	14h00	PR Newswire (US)	Correvio Announces Intention to Explore Strategic Alternatives to Maximize Stakeholder Value	NASDAQ:CORV	Correvio Pharma Corporation
10/12/2019	22h38	PR Newswire (US)	Correvio Announces Outcome Of FDA Advisory Committee Meeting Reviewing Brinavess™ For The Treatment Of Recent Onset Atrial ...	NASDAQ:CORV	Correvio Pharma Corporation
10/12/2019	13h05	PR Newswire (US)	Correvio Stock Trading Halted Today; FDA Advisory Committee Meeting To Discuss Brinavess™ For Recent Onset Atrial Fibrillat...	NASDAQ:CORV	Correvio Pharma Corporation
25/11/2019	14h00	PR Newswire (Canada)	Correvio to Present at the Piper Jaffray 31st Annual Healthcare Conference	NASDAQ:CORV	Correvio Pharma Corporation
18/11/2019	14h00	PR Newswire (Canada)	Correvio Announces Presentation of New Brinavess™ Spectrum Data at the American Heart Association 2019 Annual Meeting	NASDAQ:CORV	Correvio Pharma Corporation